U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H22FN3O
Molecular Weight 375.4387
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5F-PCN

SMILES

FCCCCCN1C=C(C(=O)NC2=CC=CC3=CC=CC=C23)C4=CN=CC=C14

InChI

InChIKey=BRRZRRZUERBDQL-UHFFFAOYSA-N
InChI=1S/C23H22FN3O/c24-12-4-1-5-14-27-16-20(19-15-25-13-11-22(19)27)23(28)26-21-10-6-8-17-7-2-3-9-18(17)21/h2-3,6-11,13,15-16H,1,4-5,12,14H2,(H,26,28)

HIDE SMILES / InChI

Approval Year

Name Type Language
5F-PCN
Common Name English
1-(5-FLUOROPENTYL)-N-(NAPHTHALEN-1-YL)-1H-PYRROLO(3,2-C)PYRIDINE-3-CARBOXAMIDE
Systematic Name English
5-F-MN-21
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-5F-PCN
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
Code System Code Type Description
PUBCHEM
125181244
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
PRIMARY
EPA CompTox
DTXSID901032641
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
PRIMARY
CAS
2219332-48-4
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
PRIMARY
FDA UNII
Q7GH2GGJ3E
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
5F-PCN
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
PRIMARY CAS: 325373-36-9 given is a non valid CAS Registry Number.
WIKIPEDIA
5F-PCN
Created by admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
PRIMARY 5F-PCN (also known as 5-F-MN-21) is an azaindole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is closely related to NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-PCN may release 1-naphthylamine, a known carcinogen. Sweden's public health agency suggested to classify 5F-PCN as hazardous substance on November 10, 2014.